- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02015897
Effect of Physical Therapy on Breast Cancer Related Lymphedema
Effect of Physical Therapy on Breast Cancer Related Lymphedema; A Multicenter, Randomized, Single-blind, Equivalence Trial
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Physical therapy treatment of patients with lymphoedema includes treatment based on the principles of 'Complete Decongestive Therapy' (CDT). CDT consists of following components; skin care, manual lymphatic drainage, bandaging and exercises. Regarding what type of treatment of treatments is most effective, the scientific evidence is sparse. Studies have focused on the time-consuming manual lymphatic drainage, but the scientific evidence is not consistent.
A randomized, single-blind, equivalence trial. A total of 160 breast cancer patients with lymphoedema will be recruited from 3 hospitals and randomised into one of two treatment groups: A: Complete Decongestive TherapyA (incl. manual drainage) or B: Complete Decongestive TherapyB (except manual lymphatic drainage
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Region Of Southern Denmark
-
Esbjerg, Region Of Southern Denmark, Denmark, 6700
- Hospital of Southwest Denmark
-
Odense, Region Of Southern Denmark, Denmark, 5000
- Department of Rehabilitation, Odense University Hospital
-
Vejle, Region Of Southern Denmark, Denmark, 7000
- Department of Physical Therapy, Lillebaelt Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- The diagnose breast cancer regardless of date for operation and identified lymphoedema
- Precede ultrasonic scanning of axilla in order to exclude local relapse
- Lymphoedema > 2 cm i.e. stage II-III
- Completed radiotherapy and/or chemotherapy at least 2 months prior inclusion
Exclusion Criteria:
- Relapse of breast cancer
- Untreated infection
- Untreated heart failure
- Untreated renal failure
- Untreated deep venous thrombosis in the arm
- Unable to participate in physiotherapy treatment and/or not able to understand instructions
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
ACTIVE_COMPARATOR: Physical TherapyB
Group B
|
Group A:
|
|
PLACEBO_COMPARATOR: Physical TherapyA
Group A
|
Group B:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
The percentage volume reduction of lymphoedema (%)
Time Frame: 7 months
|
7 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Differences in circumference of the arm (composite outcome measure), bodyweight, patient sensation of heaviness, patient sensation of tension, and quality of life
Time Frame: 7 months
|
Circumference of the arm consists of 7 measurements but these will be converted to one outcome measure when estimating the difference between baseline and post intervention measurements
|
7 months
|
Other Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Percentage volume reduction of lymphedema (%) from baseline to week 4. Percentage volume reduction of lymphedema (%) from week 4 to week 7
Time Frame: 7 months
|
7 months
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Bibi Gram, PhD, THe Hospital of Southwest Denmark
Publications and helpful links
General Publications
- Tambour M, Holt M, Speyer A, Christensen R, Gram B. Manual lymphatic drainage adds no further volume reduction to Complete Decongestive Therapy on breast cancer-related lymphoedema: a multicentre, randomised, single-blind trial. Br J Cancer. 2018 Nov;119(10):1215-1222. doi: 10.1038/s41416-018-0306-4. Epub 2018 Oct 24.
- Tambour M, Tange B, Christensen R, Gram B. Effect of physical therapy on breast cancer related lymphedema: protocol for a multicenter, randomized, single-blind, equivalence trial. BMC Cancer. 2014 Apr 3;14:239. doi: 10.1186/1471-2407-14-239.
Helpful Links
Study record dates
Study Major Dates
Study Start
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- S-20130091
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.